ARTICLE | Clinical News
Ablynx preclinical data
January 19, 2009 8:00 AM UTC
In a mouse model of viral infection, intratracheal Antiviral Nanobodies neutralized the undisclosed viral target for at least 72 hours. The Nanobodies had 5 to 10 times greater bioavailability when de...